Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1993-4-19
|
pubmed:abstractText |
The regulatory role of very low density lipoproteins (VLDL) in de novo protein synthesis and in natural killer (NK) mediated cytotoxicity against cancer cells was evaluated in IL-2 activated peripheral blood mononuclear cells (PBL). Supplementing of VLDL to the incubation medium induced a potent dose-related inhibitory effect on the synthesis and secretion of (35S) labelled proteins. The maximal inhibitory response was observed at 50 micrograms/ml cholesterol VLDL. The effect of VLDL on the IL-2 induced ability of lymphocytes to kill cancer cells and to interfere with target cell proliferation was then evaluated. Maximal cytotoxicity was observed at 50 micrograms VLDL/ml as cholesterol. This VLDL-dependent stimulatory effect was associated with a significant decrease in the proliferative effect of the medium conditioned by PBL. The possibility that VLDL mediate the regulation of immune functions by interacting with metabolic patterns expressed by IL-2 stimulated lymphocytes is discussed in light of these results.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1043-6618
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
45-52
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8456057-Adult,
pubmed-meshheading:8456057-Cells, Cultured,
pubmed-meshheading:8456057-Cytotoxicity, Immunologic,
pubmed-meshheading:8456057-Humans,
pubmed-meshheading:8456057-Interleukin-2,
pubmed-meshheading:8456057-Killer Cells, Natural,
pubmed-meshheading:8456057-Lipoproteins, VLDL,
pubmed-meshheading:8456057-Lymphocytes,
pubmed-meshheading:8456057-Protein Biosynthesis,
pubmed-meshheading:8456057-Proteins,
pubmed-meshheading:8456057-Tumor Cells, Cultured
|
pubmed:articleTitle |
Regulatory relevance of lipoproteins in interleukin-2 stimulated lymphocytes in vitro.
|
pubmed:affiliation |
Institute of Endocrinology, University of Milan, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|